Search
Search Results
- Author(s):
- Cubanski, Juliette, author
Neuman, Tricia, author
- Publication:
- San Francisco, CA : Henry J. Kaiser Family Foundation, April 2018
- Subject(s):
- Drug Costs
Medicare Part D -- economics
Negotiating
Prescription Drugs -- economics
Cost Savings
Humans
United States
- Author(s):
- Young, Katherine, author
- Publication:
- San Francisco, CA : Henry J. Kaiser Family Foundation, May 2018
- Subject(s):
- Cost Control
Drug Costs
Medicaid -- economics
Prescription Drugs -- economics
Formularies as Topic
Humans
United States
United States.
- Author(s):
- Dayoub, Elias J., author
Seigerman, Matthew, author
Tuteja, Sony, author
Kobayashi, Taisei, author
Kolansky, Daniel, author
Giri, Jay, author
Groeneveld, Peter, author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
- Subject(s):
- Medication Adherence -- statistics & numerical data
Percutaneous Coronary Intervention
Purinergic P2Y Receptor Antagonists -- therapeutic use
Socioeconomic Factors
Drug Costs
Drugs, Generic -- economics
Drugs, Generic -- therapeutic use
Platelet Aggregation Inhibitors -- economics
Platelet Aggregation Inhibitors -- therapeutic use
Purinergic P2Y Receptor Antagonists -- economics
Social Determinants of Health
Humans
United States
- Author(s):
- Waxman, Henry, author
Corr, Bill, author
Martin, Kristi, author
Duong, Sophia, author
- Publication:
- [New York, N.Y.] : Commonwealth Fund, July 2017
- Subject(s):
- Cost Control
Drug Costs
Health Policy
Prescription Drugs -- economics
Drug Industry -- economics
Drugs, Generic -- economics
Economic Competition
Legislation, Drug
Orphan Drug Production -- economics
Humans
United States
- Author(s):
- Cubanski, Juliette, author
Neuman, Tricia, author
Orgera, Kendal, author
Damico, Anthony, author
- Publication:
- Menlo Park, CA : Henry J. Kaiser Family Foundation, November 2017
- Subject(s):
- Drug Costs
Financing, Personal
Health Expenditures
Medicare Part D -- economics
Medicare Part D -- trends
Chronic Disease -- drug therapy
Chronic Disease -- economics
Demography
Hepatitis C -- drug therapy
Leukemia -- drug therapy
Lymphoma -- drug therapy
Poverty
Humans
United States
- Author(s):
- Doshi, Jalpa A., author
Li, Pengxiang, author
Huo, Hairong, author
Pettit, Amy R., author
Armstrong, Katrina A., author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
- Subject(s):
- Antineoplastic Agents -- economics
Antineoplastic Agents -- therapeutic use
Drug Costs
Financing, Personal -- statistics & numerical data
Medication Adherence -- statistics & numerical data
Administration, Oral
Antineoplastic Agents -- administration & dosage
Health Services Accessibility
Prescription Drugs -- economics
Socioeconomic Factors
Time Factors
Humans
United States
- Author(s):
- Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, March 2017
- Subject(s):
- Drug Costs
Insurance Coverage
Medicare Part D -- economics
Cost Savings
Deductibles and Coinsurance
Financing, Personal
Medicare -- legislation & jurisprudence
Humans
United States
United States.
- Author(s):
- Carter, Elizabeth A., author
Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, August 2018
- Subject(s):
- Dementia -- drug therapy
Dementia -- economics
Drug Costs
Inappropriate Prescribing -- economics
Aged
Cholinesterase Inhibitors -- economics
Cholinesterase Inhibitors -- therapeutic use
Cost Savings
Drug Therapy, Combination
Memantine -- economics
Memantine -- therapeutic use
Humans
United States
- Author(s):
- Johnson, Bill, author
Rodriguez, Sally, author
- Publication:
- Washington, DC : Health Care Cost Institute, February 2018
- Subject(s):
- Financing, Personal
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Drug Costs
Forecasting
Insurance, Health -- economics
Insurance, Pharmaceutical Services -- economics
Private Sector
Humans
United States
- Author(s):
- Johnson, Bill, author
- Publication:
- Washington, DC : Health Care Cost Institute, April 2018
- Subject(s):
- Drug Costs
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Multiple Sclerosis -- economics
Multiple Sclerosis -- drug therapy
Dihydroorotate Oxidase -- antagonists & inhibitors
Dimethyl Fumarate -- economics
Fingolimod Hydrochloride -- economics
Forecasting
Glatiramer Acetate -- economics
Interferon beta-1a -- economics
Interferon beta-1b -- economics
Humans
United States